Xponential 10-Q: Q3 Revenue Down 21%, Cash Falls to $27.2M, Material Weakness Persists
XPOF sits 33% above its 52-week low of $3.565.
Summary
Xponential's Q3 10-Q confirms a 21% revenue decline to $62.3 million, negative $21.1 million of operating cash flow, and an unremediated material weakness in internal controls, with $521.1 million of debt outstanding.
Key Events · Earnings and Guidance · XPOF
-
Q3 Revenue Falls 21%
Total revenue was $62.3 million versus $78.8 million a year earlier, with same store sales down 8% compared with a 1% decline in Q3 2025.
-
Cash Burn and Liquidity Tighten
Cash, cash equivalents and restricted cash fell to $27.2 million from $45.9 million at December 31, 2025, and operating activities used $21.1 million in the nine months versus $17.6 million generated a year earlier.
-
Material Weakness Still Unremediated
Management concluded disclosure controls and procedures were not effective at September 30, 2026 because the previously disclosed material weakness in accounting resources and IT general controls remains unresolved.
-
Debt Load Weighs on Results
$521.1 million of term loan principal is outstanding under the HPS credit agreement at a 10.5% rate, with $10 million drawn on the revolver; interest expense rose to $44.6 million for nine months from $37.3 million.
Analysis · XPOF · Trade & Services
The Q3 numbers were already out on November 5, but the full 10-Q confirms how thin the cushion is. Revenue fell 21% to $62.3 million and same store sales dropped 8%, while cash and restricted cash fell to $27.2 million from $45.9 million at year-end and operations burned $21.1 million in nine months. Against $521.1 million of term debt at a 10.5% rate, that leaves little room. Management again concluded disclosure controls were not effective because the previously disclosed material weakness in accounting resources and IT controls is still unremediated. The quarter's $4.9 million net income is flattered by a $3.8 million non-cash contingent consideration gain, not by better operations.
How filings like this one have moved
In the 30 days to Nov 9, 2026, 47.1% of the 1533 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, XPOF was trading at $4.74 on NYSE in the Trade & Services sector, with a market capitalization of approximately $233.1M. The 52-week trading range was $3.57 to $9.25. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.